Increased CSF glutamate following injection of ALS immunoglobulins

To reconcile the autoimmune and excitotoxic hypotheses regarding the etiology of amyotrophic lateral sclerosis (ALS), we injected rats intraperitoneally with ALS immunoglobulins and monitored CSF glutamate, aspartate, glutamine, and glutathione. CSF glutamate was significantly increased at 24 and 72 hours compared with both basal levels and disease control injected rats. CSF aspartate was increased at 72 hours. Glutamine and glutathione were unchanged. These data suggest that ALS immunoglobulins may enhance CSF glutamate and aspartate levels and contribute to motoneuron injury.

[1]  J. Weiss,et al.  Motor Neurons Are Selectively Vulnerable to AMPA/Kainate Receptor-Mediated Injury In Vitro , 1996, The Journal of Neuroscience.

[2]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[3]  L. Komuves,et al.  Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons , 1995, Synapse.

[4]  E. Stefani,et al.  Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line , 1995, Annals of neurology.

[5]  V. La Bella,et al.  The role of calcium‐binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis , 1994, Annals of neurology.

[6]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[7]  C. Ferrarese,et al.  Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid , 1993, Annals of neurology.

[8]  W. Heiss,et al.  Ischemia‐Induced Accumulation of Extracellular Amino Acids in Cerebral Cortex, White Matter, and Cerebrospinal Fluid , 1993, Journal of neurochemistry.

[9]  E. Stefani,et al.  Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[11]  E. Stefani,et al.  Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis. , 1995, Advances in neurology.

[12]  J. Rothstein.  Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. , 1995, Advances in neurology.

[13]  T. Halonen,et al.  Amino acid levels in cerebrospinal fluid of rats after administration of pentylenetetrazol. , 1992, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.